Procurement of Vandefitemcel and Onasemnogene Abeparvovec Sets
Open tenderJapanese title: A バンデフィテムセル一式Bオナセムノゲンアベパルボベク一式
Overview
The National University Corporation Hokkaido University is conducting an open tender for the purchase of one set each of Vandefitemcel and Onasemnogene Abeparvovec. Delivery is required between September 1, 2026 and May 31, 2027 to Hokkaido University Hospital. Participation requires appropriate licensing for regenerative medicine product sales and proven delivery capability.
Key Details
- Source: Kanpo
- Notice type: Open tender
- Publication date: June 24, 2026
- Procuring entity: Kiyohiro HOUKIN, President, The National University Corporation Hokkaido University
- Submission deadline: August 14, 2026, 17:00 JST
- Delivery period: September 1, 2026 – May 31, 2027
- Bid opening: August 27, 2026, 13:30 JST, location: see the official notice
- Award method: Lowest-price award
- Eligibility (from notice): All-ministry unified qualification, 'goods sales', grade A–C, Hokkaido region – verify in the tender documents
- Status: Expired
- Technology relevance: Possible
- Business-action likelihood: Medium – Participation requires specific licensing and regional qualification, and delivery must meet strict conditions set by the university, indicating moderate barriers and need for compliance.
Official Notice
Official Source
Kanpo, Japan's official government gazette, in which legally required public procurement notices are formally published.
- Source: Kanpo, Government Procurement Notice Edition
- Official category: 入札公告 / Open competitive tender notice
- Publication date: June 24, 2026
- Publication: Kanpo, pages 17
Full English Translation
The following English translation was prepared from the original Japanese notice published in Kanpo. Where an official English summary appears in the Kanpo publication, it was used only for verification; the translation below is based on the Japanese source text.
The following items are subject to open competitive bidding. Date: June 24, 2026. Procuring Entity: Kiyohiro HOUKIN, President, The National University Corporation Hokkaido University. Procurement Agency Number: 415. Location Number: 01.
1. Procurement Details:
(1) Item Classification Number: 4.
(2) Subject and Quantity: One set of Vandefitemcel and one set of Onasemnogene Abeparvovec.
(3) Characteristics of the procurement subject: As described in the bidding documents.
(4) Delivery Period: From September 1, 2026 to May 31, 2027.
(5) Delivery Location: Hokkaido University Hospital.
(6) Bidding Method: Bidders shall state the unit price per set. The winning bid price will be the bid amount plus 10% of that amount; bidders must state the amount equivalent to 100/110 of the estimated contract amount regardless of tax status.
2. Eligibility for Participation:
(1) Must be rated Grade A, B, or C in the Hokkaido region for 'sales of goods' under national or Hokkaido University competitive qualifications for fiscal 2026. Applications accepted at designated government procurement offices or Hokkaido University Finance Department Procurement Section.
(2) Must prove possession of a license to sell regenerative medicine products under the Law on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices.
(3) Must prove ability to deliver the items at the date and place designated by the President.
(4) Must not be under suspension of business by the President.
3. Submission of Bids:
(1) Submission Location, Contract Terms, Bidding Document Distribution and Contact: Hokkaido University Hospital Management Section, Pharmaceutical Department, Attn: Kobayashi Yoshiki, Phone 011-706-7405, 060-8648 Sapporo, Kita 14-jo Nishi 5-chome.
(2) Bidding documents available from the date of this notice at the above location.
(3) Bid Submission Deadline: August 14, 2026, 17:00.
(4) Bid Opening Date and Location: August 27, 2026, 13:30, Hokkaido University Hospital Management Section Bidding Room.
4. Others:
(1) Language and Currency for Contract: Japanese and Japanese Yen.
(2) Bid and Contract Guarantees: Exempted.
(3) Required Documents: Bidders must submit sealed bids with documents proving ability to deliver the items by the deadline. Bidders must respond to explanations requested by the President before bid opening.
(4) Invalid Bids: Bids from ineligible participants or those failing obligations will be invalid.
(5) Contract Document: Required.
(6) Award Method: The President will award the contract to the lowest valid bid within the estimated price limit from bidders judged able to deliver the items.
(7) Negotiations: None.
(8) Further details in bidding documents. If environmental conditions are specified in the bidding documents, bidders must understand them fully before bidding.
Show original Japanese notice
The full Japanese notice text is temporarily hidden on this page due to a text-extraction defect. The official notice is available via the Kanpo source link on this page.
Business Signal
Business Relevance
May interest companies providing advanced regenerative medicine products and pharmaceutical supply chain services.
Participation fit
Participation is expected to require appropriate Japanese government procurement eligibility, or cooperation with a suitable Japanese partner holding the required qualification. The eligibility requirements have not been fully reviewed and should be verified against the official tender documents.
This page is based on the official Kanpo tender notice, with translation and a preliminary business assessment by I.J. Do. The official Japanese notice and tender documents are binding.
JBid is a beta technology-procurement intelligence service by I.J. Do.